Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9157813 | Atherosclerosis | 2005 | 6 Pages |
Abstract
Thus, in patients with severe LDL-hypercholesterolemia and CHD the addition of ezetimibe to intensive lipid lowering therapy (statins and LDL-apheresis) resulted in a further, clinically significant decrease of LDL-cholesterol.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
H.C. Geiss, C. Otto, E. Hund-Wissner, K.G. Parhofer,